Critical Therapeutics, Inc. (CRTX) Announces Stockholder Approvals Related to Merger with Cornerstone BioPharma, Inc. and 10-to-1 Reverse Stock Split
10/31/2008 11:16:58 AM
More...
|
Critical Therapeutics, Inc. (CRTX) Reports Financial Results for the Third Quarter Ended September 30, 2008
10/21/2008 10:28:01 AM
More...
|
Critical Therapeutics, Inc. (CRTX) Announces Effectiveness Of Registration Statement For The Proposed Merger With Cornerstone BioPharma, Inc.
10/6/2008 10:53:23 AM
More...
|
Critical Therapeutics, Inc. (CRTX) Receives Notice of Additional Deficiency from NASDAQ
8/14/2008 11:25:16 PM
More...
|
Critical Therapeutics, Inc. (CRTX) Reports Financial Results for the Second Quarter Ended June 30, 2008
8/11/2008 11:00:52 PM
More...
|
Critical Therapeutics, Inc. (CRTX) to Report Second Quarter 2008 Financial Results on August 11
8/7/2008 8:45:47 AM
More...
|
Critical Therapeutics, Inc. (CRTX) Files Registration Statement on Form S-4 with Securities and Exchange Commission
7/22/2008 9:13:41 AM
More...
|
Critical Therapeutics, Inc. (CRTX) Announces Stock Listing Transfer From NASDAQ Global Market to NASDAQ Capital Market
6/17/2008 11:14:58 AM
More...
|
Critical Therapeutics, Inc. (CRTX) Completes Phase II Clinical Trial for Zileuton Injection
6/3/2008 8:50:18 AM
More...
|
Critical Therapeutics, Inc. (CRTX) Receives Notice of Additional Deficiency from NASDAQ
5/21/2008 8:45:08 AM
More...
|
|